James Falko
Concepts (416)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperlipoproteinemia Type I | 1 | 2018 | 7 | 0.670 |
Why?
| Alcohol Abstinence | 1 | 2018 | 10 | 0.670 |
Why?
| Plasmapheresis | 1 | 2018 | 24 | 0.660 |
Why?
| Hyperlipidemias | 8 | 2006 | 134 | 0.660 |
Why?
| Diet, Fat-Restricted | 1 | 2018 | 76 | 0.650 |
Why?
| Anticholesteremic Agents | 4 | 2012 | 136 | 0.550 |
Why?
| Diabetic Angiopathies | 4 | 2005 | 270 | 0.550 |
Why?
| Diabetic Neuropathies | 2 | 2005 | 100 | 0.490 |
Why?
| Hyperlipoproteinemia Type II | 3 | 2016 | 26 | 0.480 |
Why?
| Metabolic Syndrome | 3 | 2008 | 395 | 0.420 |
Why?
| Lipoproteins | 10 | 1997 | 164 | 0.400 |
Why?
| Hypothyroidism | 4 | 2018 | 69 | 0.390 |
Why?
| Diabetes Mellitus, Type 2 | 12 | 2005 | 2221 | 0.370 |
Why?
| Cardiovascular Diseases | 3 | 2012 | 1859 | 0.330 |
Why?
| Cholesterol, LDL | 9 | 2012 | 326 | 0.320 |
Why?
| Lipoproteins, LDL | 11 | 1997 | 138 | 0.310 |
Why?
| Hyperthyroidism | 8 | 1997 | 27 | 0.300 |
Why?
| Hypolipidemic Agents | 3 | 2006 | 88 | 0.290 |
Why?
| Fenofibrate | 2 | 2003 | 24 | 0.290 |
Why?
| Lipoproteins, HDL | 11 | 2008 | 82 | 0.270 |
Why?
| Blood Component Removal | 2 | 2016 | 35 | 0.240 |
Why?
| Insulin | 16 | 1991 | 2180 | 0.240 |
Why?
| Pancreatitis | 5 | 2018 | 112 | 0.240 |
Why?
| Rhabdomyolysis | 1 | 2003 | 19 | 0.230 |
Why?
| Dyslipidemias | 1 | 2005 | 165 | 0.230 |
Why?
| Dietary Fats | 5 | 1996 | 325 | 0.230 |
Why?
| Blood Glucose | 20 | 2008 | 1957 | 0.230 |
Why?
| Triglycerides | 11 | 2008 | 527 | 0.220 |
Why?
| Diagnosis, Differential | 8 | 2018 | 1423 | 0.220 |
Why?
| Hypertriglyceridemia | 2 | 2018 | 39 | 0.220 |
Why?
| Cholesterol, HDL | 8 | 2005 | 202 | 0.220 |
Why?
| Cholesterol | 12 | 2006 | 380 | 0.190 |
Why?
| Apolipoproteins | 6 | 1984 | 40 | 0.180 |
Why?
| Thyroid Neoplasms | 6 | 1998 | 277 | 0.180 |
Why?
| Xanthomatosis | 2 | 2018 | 11 | 0.180 |
Why?
| Hepatomegaly | 1 | 2018 | 2 | 0.170 |
Why?
| Hyperlipoproteinemia Type IV | 3 | 1996 | 3 | 0.170 |
Why?
| Splenomegaly | 1 | 2018 | 17 | 0.170 |
Why?
| Nephrotic Syndrome | 1 | 2018 | 33 | 0.160 |
Why?
| Lipoprotein Lipase | 1 | 2018 | 69 | 0.160 |
Why?
| Humans | 88 | 2018 | 122796 | 0.160 |
Why?
| Dietary Carbohydrates | 4 | 1986 | 154 | 0.160 |
Why?
| Thyroid Nodule | 1 | 1998 | 38 | 0.160 |
Why?
| Carcinoma, Papillary | 1 | 1998 | 78 | 0.160 |
Why?
| Lipoproteins, VLDL | 7 | 1984 | 20 | 0.160 |
Why?
| Endocrinology | 1 | 2018 | 69 | 0.150 |
Why?
| Abdominal Pain | 1 | 2018 | 141 | 0.150 |
Why?
| Diabetes Mellitus | 6 | 2018 | 985 | 0.150 |
Why?
| Glyburide | 3 | 1985 | 43 | 0.150 |
Why?
| Gastrointestinal Hormones | 4 | 1982 | 8 | 0.150 |
Why?
| Arteriosclerosis | 4 | 1997 | 90 | 0.150 |
Why?
| Adenoma, Islet Cell | 3 | 1984 | 10 | 0.150 |
Why?
| Genetic Therapy | 1 | 2018 | 265 | 0.140 |
Why?
| C-Peptide | 7 | 1986 | 137 | 0.140 |
Why?
| Insulinoma | 3 | 1984 | 31 | 0.140 |
Why?
| Cost of Illness | 1 | 2018 | 284 | 0.140 |
Why?
| Gastric Inhibitory Polypeptide | 4 | 1986 | 13 | 0.140 |
Why?
| Lipids | 6 | 2006 | 614 | 0.140 |
Why?
| Lipoprotein(a) | 1 | 2016 | 49 | 0.140 |
Why?
| Female | 67 | 2016 | 63629 | 0.130 |
Why?
| Recurrence | 1 | 2018 | 998 | 0.130 |
Why?
| Middle Aged | 41 | 2016 | 28563 | 0.130 |
Why?
| Fatty Acids, Omega-3 | 1 | 1996 | 127 | 0.130 |
Why?
| Niacin | 2 | 2005 | 20 | 0.120 |
Why?
| Obesity | 7 | 2010 | 2786 | 0.120 |
Why?
| Sucrose | 3 | 1986 | 105 | 0.120 |
Why?
| Glucose Tolerance Test | 5 | 1987 | 370 | 0.110 |
Why?
| Alcoholism | 2 | 2018 | 725 | 0.110 |
Why?
| Receptors, LDL | 1 | 2012 | 41 | 0.110 |
Why?
| Thrombosis | 1 | 2016 | 319 | 0.110 |
Why?
| Hyperparathyroidism | 3 | 1984 | 12 | 0.110 |
Why?
| Adult | 46 | 2008 | 32385 | 0.110 |
Why?
| Plaque, Atherosclerotic | 1 | 2012 | 45 | 0.110 |
Why?
| Glucose | 7 | 1986 | 968 | 0.100 |
Why?
| Pheochromocytoma | 2 | 1990 | 54 | 0.100 |
Why?
| Drug Design | 1 | 2012 | 163 | 0.100 |
Why?
| Adrenal Gland Neoplasms | 2 | 1990 | 82 | 0.100 |
Why?
| Male | 50 | 2010 | 59639 | 0.100 |
Why?
| Pregnancy Complications | 1 | 1996 | 462 | 0.100 |
Why?
| Hyperaldosteronism | 1 | 1990 | 8 | 0.100 |
Why?
| Hypercalcemia | 2 | 1984 | 22 | 0.100 |
Why?
| Splenic Neoplasms | 1 | 1990 | 4 | 0.100 |
Why?
| Adrenal Hyperplasia, Congenital | 1 | 1990 | 29 | 0.100 |
Why?
| Multiple Endocrine Neoplasia | 1 | 1990 | 6 | 0.100 |
Why?
| Hyperlipoproteinemia Type III | 2 | 1980 | 3 | 0.090 |
Why?
| Coronary Artery Disease | 2 | 2006 | 695 | 0.090 |
Why?
| Pancreatic Neoplasms | 4 | 1984 | 803 | 0.090 |
Why?
| Musculoskeletal Diseases | 1 | 2010 | 74 | 0.090 |
Why?
| Age Factors | 3 | 2012 | 3114 | 0.080 |
Why?
| Lipid Metabolism | 3 | 2006 | 482 | 0.080 |
Why?
| Fructose | 3 | 1987 | 204 | 0.080 |
Why?
| Quality of Life | 1 | 2018 | 2457 | 0.080 |
Why?
| Diuretics | 2 | 1986 | 78 | 0.080 |
Why?
| Indapamide | 1 | 1986 | 1 | 0.070 |
Why?
| Physical Therapy Modalities | 1 | 2010 | 283 | 0.070 |
Why?
| Apoproteins | 1 | 1986 | 11 | 0.070 |
Why?
| Metoclopramide | 1 | 1986 | 18 | 0.070 |
Why?
| Stomach Diseases | 1 | 1986 | 20 | 0.070 |
Why?
| Optic Atrophy | 1 | 1986 | 11 | 0.070 |
Why?
| Cyclosporins | 1 | 1986 | 60 | 0.070 |
Why?
| Community Health Services | 1 | 2008 | 216 | 0.070 |
Why?
| Liver Neoplasms | 1 | 1990 | 546 | 0.070 |
Why?
| Hyponatremia | 1 | 1986 | 45 | 0.070 |
Why?
| Shoes | 1 | 2005 | 26 | 0.070 |
Why?
| Muscular Diseases | 1 | 1986 | 108 | 0.070 |
Why?
| Weight Loss | 2 | 2010 | 663 | 0.070 |
Why?
| Disease Progression | 1 | 2012 | 2546 | 0.070 |
Why?
| Lupus Erythematosus, Systemic | 2 | 1979 | 235 | 0.070 |
Why?
| Heptanoic Acids | 1 | 2005 | 64 | 0.070 |
Why?
| Sulfonylurea Compounds | 1 | 1985 | 43 | 0.060 |
Why?
| Medical History Taking | 1 | 2005 | 121 | 0.060 |
Why?
| Deafness | 1 | 1986 | 80 | 0.060 |
Why?
| Radionuclide Imaging | 6 | 1998 | 134 | 0.060 |
Why?
| Diabetic Foot | 1 | 2005 | 55 | 0.060 |
Why?
| Pregnancy Complications, Neoplastic | 1 | 1984 | 52 | 0.060 |
Why?
| Pain | 1 | 2010 | 746 | 0.060 |
Why?
| Pyrroles | 1 | 2005 | 199 | 0.060 |
Why?
| Iodine Radioisotopes | 3 | 1998 | 128 | 0.060 |
Why?
| Diabetes Complications | 1 | 2005 | 226 | 0.060 |
Why?
| Fish Oils | 1 | 2003 | 26 | 0.060 |
Why?
| Clinical Trials as Topic | 2 | 2005 | 985 | 0.060 |
Why?
| C-Reactive Protein | 1 | 2005 | 363 | 0.060 |
Why?
| Ezetimibe | 1 | 2003 | 25 | 0.060 |
Why?
| Physical Examination | 1 | 2005 | 253 | 0.060 |
Why?
| Azetidines | 1 | 2003 | 29 | 0.060 |
Why?
| Diabetes Mellitus, Type 1 | 4 | 1991 | 3388 | 0.060 |
Why?
| Ultrasonography | 2 | 1984 | 740 | 0.060 |
Why?
| Furosemide | 2 | 1986 | 34 | 0.060 |
Why?
| Diabetes Mellitus, Experimental | 1 | 1984 | 213 | 0.060 |
Why?
| Coronary Disease | 1 | 2005 | 372 | 0.060 |
Why?
| Time Factors | 8 | 2006 | 6682 | 0.060 |
Why?
| 1-Propanol | 1 | 1982 | 1 | 0.050 |
Why?
| Aged | 13 | 2006 | 20495 | 0.050 |
Why?
| Particle Size | 1 | 2003 | 344 | 0.050 |
Why?
| Patient Care Team | 1 | 2006 | 520 | 0.050 |
Why?
| Heart Diseases | 1 | 2005 | 358 | 0.050 |
Why?
| Osteoporosis | 1 | 1985 | 234 | 0.050 |
Why?
| Mutation | 1 | 2012 | 3493 | 0.050 |
Why?
| Apolipoproteins C | 2 | 1982 | 6 | 0.050 |
Why?
| Exercise Therapy | 1 | 2005 | 375 | 0.050 |
Why?
| Empty Sella Syndrome | 1 | 1981 | 1 | 0.050 |
Why?
| Metrizamide | 1 | 1981 | 1 | 0.050 |
Why?
| Hypertension | 3 | 1986 | 1245 | 0.050 |
Why?
| Copper | 2 | 1997 | 101 | 0.050 |
Why?
| Hyperlipoproteinemia Type V | 1 | 1979 | 1 | 0.050 |
Why?
| Hyperlipoproteinemias | 1 | 1979 | 6 | 0.050 |
Why?
| Ethinyl Estradiol | 1 | 1979 | 17 | 0.050 |
Why?
| Sodium Pertechnetate Tc 99m | 2 | 1998 | 6 | 0.040 |
Why?
| Drug Therapy, Combination | 4 | 1991 | 988 | 0.040 |
Why?
| Kidney Transplantation | 1 | 1986 | 584 | 0.040 |
Why?
| Calcium | 2 | 1984 | 1244 | 0.040 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2003 | 410 | 0.040 |
Why?
| Central Nervous System Diseases | 1 | 1979 | 64 | 0.040 |
Why?
| Insulin Infusion Systems | 1 | 1982 | 305 | 0.040 |
Why?
| Sodium Iodide | 1 | 1998 | 4 | 0.040 |
Why?
| Tomography, X-Ray Computed | 5 | 1993 | 2500 | 0.040 |
Why?
| Medicine, Ayurvedic | 1 | 1997 | 3 | 0.040 |
Why?
| Primary Health Care | 2 | 2006 | 1625 | 0.040 |
Why?
| Pancreatic Juice | 1 | 1977 | 2 | 0.040 |
Why?
| Oxidation-Reduction | 2 | 1997 | 931 | 0.040 |
Why?
| Water-Electrolyte Balance | 1 | 1977 | 32 | 0.040 |
Why?
| Lipid Peroxidation | 1 | 1997 | 151 | 0.040 |
Why?
| Phytotherapy | 1 | 1997 | 72 | 0.040 |
Why?
| Hypoglycemic Agents | 1 | 1985 | 1055 | 0.040 |
Why?
| Radiopharmaceuticals | 1 | 1998 | 196 | 0.040 |
Why?
| Drug Resistance | 1 | 1997 | 169 | 0.040 |
Why?
| Thyroid Gland | 3 | 1982 | 86 | 0.040 |
Why?
| Acidosis, Renal Tubular | 1 | 1976 | 7 | 0.040 |
Why?
| Diazoxide | 1 | 1977 | 32 | 0.040 |
Why?
| Stomach | 2 | 1983 | 109 | 0.040 |
Why?
| Oils | 2 | 1976 | 20 | 0.040 |
Why?
| Multiple Endocrine Neoplasia Type 2b | 1 | 1996 | 6 | 0.040 |
Why?
| Pituitary Neoplasms | 3 | 1982 | 166 | 0.040 |
Why?
| Carcinoma, Medullary | 1 | 1996 | 14 | 0.040 |
Why?
| Proto-Oncogenes | 1 | 1996 | 28 | 0.040 |
Why?
| Multiple Endocrine Neoplasia Type 2a | 1 | 1996 | 9 | 0.040 |
Why?
| Magnesium Deficiency | 1 | 1976 | 2 | 0.040 |
Why?
| Polycythemia | 1 | 1976 | 27 | 0.040 |
Why?
| Procainamide | 1 | 1975 | 5 | 0.040 |
Why?
| Body Mass Index | 3 | 2010 | 2144 | 0.030 |
Why?
| Reference Values | 1 | 1997 | 789 | 0.030 |
Why?
| Adolescent | 12 | 1998 | 18948 | 0.030 |
Why?
| Hypocalcemia | 1 | 1976 | 32 | 0.030 |
Why?
| Bone Resorption | 1 | 1976 | 80 | 0.030 |
Why?
| Pancreas | 1 | 1977 | 295 | 0.030 |
Why?
| Anemia | 1 | 1976 | 156 | 0.030 |
Why?
| Pancreatic Cyst | 1 | 1975 | 49 | 0.030 |
Why?
| Acute Kidney Injury | 1 | 1982 | 755 | 0.030 |
Why?
| Graves Disease | 3 | 1985 | 33 | 0.030 |
Why?
| Orbital Pseudotumor | 1 | 1993 | 3 | 0.030 |
Why?
| Antioxidants | 1 | 1997 | 581 | 0.030 |
Why?
| Hypopituitarism | 1 | 1993 | 15 | 0.030 |
Why?
| Postpartum Period | 1 | 1996 | 281 | 0.030 |
Why?
| Pregnancy Outcome | 1 | 1996 | 364 | 0.030 |
Why?
| Cranial Nerve Diseases | 1 | 1993 | 42 | 0.030 |
Why?
| Paralysis | 1 | 1993 | 68 | 0.030 |
Why?
| Animals | 2 | 2012 | 34133 | 0.030 |
Why?
| Fasting | 3 | 2006 | 266 | 0.030 |
Why?
| Cholestasis | 1 | 1975 | 236 | 0.030 |
Why?
| Isoelectric Focusing | 3 | 1982 | 38 | 0.030 |
Why?
| Thyrotropin | 2 | 1982 | 108 | 0.030 |
Why?
| Cohort Studies | 3 | 2006 | 5294 | 0.030 |
Why?
| Octreotide | 1 | 1991 | 27 | 0.020 |
Why?
| Androgen-Insensitivity Syndrome | 1 | 1990 | 6 | 0.020 |
Why?
| Patient Education as Topic | 2 | 2006 | 717 | 0.020 |
Why?
| Sex Factors | 2 | 2006 | 1860 | 0.020 |
Why?
| Double-Blind Method | 2 | 1985 | 1711 | 0.020 |
Why?
| Diet, Diabetic | 2 | 1987 | 33 | 0.020 |
Why?
| Body Fat Distribution | 1 | 2010 | 46 | 0.020 |
Why?
| Peptides | 1 | 1975 | 893 | 0.020 |
Why?
| Hypoglycemia | 2 | 1984 | 406 | 0.020 |
Why?
| Ketone Bodies | 2 | 1991 | 17 | 0.020 |
Why?
| Body Weight | 2 | 1986 | 958 | 0.020 |
Why?
| Secretory Rate | 2 | 1980 | 16 | 0.020 |
Why?
| United States | 2 | 2005 | 13272 | 0.020 |
Why?
| Pregnancy | 2 | 1996 | 5854 | 0.020 |
Why?
| Risk Factors | 3 | 2008 | 9381 | 0.020 |
Why?
| Myocardial Infarction | 1 | 1977 | 1134 | 0.020 |
Why?
| Technetium | 2 | 1981 | 24 | 0.020 |
Why?
| Brain | 1 | 1981 | 2540 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 2 | 2005 | 1981 | 0.020 |
Why?
| Thyroxine | 2 | 1981 | 64 | 0.020 |
Why?
| Treatment Outcome | 3 | 2008 | 9692 | 0.020 |
Why?
| Adenoma | 2 | 1982 | 196 | 0.020 |
Why?
| Ohio | 1 | 2008 | 144 | 0.020 |
Why?
| Pain Measurement | 1 | 2010 | 481 | 0.020 |
Why?
| Body Size | 1 | 2008 | 95 | 0.020 |
Why?
| Sweetening Agents | 1 | 1987 | 53 | 0.020 |
Why?
| Suppositories | 1 | 1986 | 5 | 0.020 |
Why?
| Pain Management | 1 | 2010 | 306 | 0.020 |
Why?
| Gastric Emptying | 1 | 1986 | 40 | 0.020 |
Why?
| Demeclocycline | 1 | 1986 | 3 | 0.020 |
Why?
| Fitness Centers | 1 | 2006 | 4 | 0.020 |
Why?
| Ticlopidine | 1 | 2006 | 71 | 0.020 |
Why?
| Drug Administration Schedule | 2 | 2005 | 757 | 0.020 |
Why?
| Carbohydrate Metabolism | 1 | 1986 | 50 | 0.020 |
Why?
| Electrolytes | 1 | 1986 | 62 | 0.020 |
Why?
| Fluorescein Angiography | 1 | 1986 | 103 | 0.020 |
Why?
| Carcinoembryonic Antigen | 1 | 1985 | 40 | 0.020 |
Why?
| Premenstrual Syndrome | 1 | 1985 | 27 | 0.020 |
Why?
| Acute Disease | 3 | 1982 | 984 | 0.020 |
Why?
| Atrophy | 1 | 1986 | 167 | 0.020 |
Why?
| Decalcification, Pathologic | 1 | 1985 | 1 | 0.020 |
Why?
| Fibrous Dysplasia of Bone | 1 | 1985 | 5 | 0.020 |
Why?
| Osteomalacia | 1 | 1985 | 4 | 0.020 |
Why?
| Anthropometry | 1 | 2006 | 200 | 0.020 |
Why?
| Lung Neoplasms | 2 | 1990 | 2216 | 0.020 |
Why?
| Placebos | 1 | 1985 | 204 | 0.020 |
Why?
| Retrospective Studies | 3 | 2008 | 13433 | 0.020 |
Why?
| Sodium Chloride | 1 | 1986 | 154 | 0.020 |
Why?
| Blood Protein Electrophoresis | 1 | 1984 | 7 | 0.020 |
Why?
| Cost-Benefit Analysis | 2 | 1984 | 573 | 0.020 |
Why?
| Pentamidine | 1 | 1984 | 3 | 0.020 |
Why?
| Insulin Antagonists | 1 | 1984 | 6 | 0.020 |
Why?
| Infant, Newborn | 1 | 1996 | 5430 | 0.020 |
Why?
| Neoplasm Recurrence, Local | 1 | 1990 | 903 | 0.020 |
Why?
| Amidines | 1 | 1984 | 16 | 0.020 |
Why?
| Thyroid Diseases | 1 | 1984 | 32 | 0.020 |
Why?
| Probability | 1 | 2005 | 316 | 0.020 |
Why?
| Rats, Inbred Strains | 1 | 1984 | 392 | 0.020 |
Why?
| Parathyroid Neoplasms | 1 | 1984 | 11 | 0.020 |
Why?
| Adrenergic beta-Antagonists | 1 | 2006 | 334 | 0.020 |
Why?
| Patient Participation | 1 | 2008 | 371 | 0.020 |
Why?
| Palliative Care | 1 | 1990 | 632 | 0.020 |
Why?
| Exercise Tolerance | 1 | 2005 | 245 | 0.020 |
Why?
| Adrenal Gland Diseases | 1 | 1983 | 7 | 0.010 |
Why?
| Parathyroid Hormone | 1 | 1984 | 99 | 0.010 |
Why?
| Blood Proteins | 1 | 1985 | 249 | 0.010 |
Why?
| Program Evaluation | 1 | 2008 | 880 | 0.010 |
Why?
| Abortion, Induced | 1 | 1984 | 73 | 0.010 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2006 | 425 | 0.010 |
Why?
| Chromatography | 1 | 1982 | 26 | 0.010 |
Why?
| Nicotinic Acids | 1 | 1982 | 6 | 0.010 |
Why?
| Pancreatectomy | 1 | 1984 | 191 | 0.010 |
Why?
| Gastrins | 1 | 1982 | 9 | 0.010 |
Why?
| Diet | 1 | 2010 | 1168 | 0.010 |
Why?
| Diabetes Insipidus | 1 | 1982 | 8 | 0.010 |
Why?
| Lymphoma | 1 | 1983 | 185 | 0.010 |
Why?
| Administration, Oral | 2 | 1984 | 786 | 0.010 |
Why?
| Hemoglobin A | 1 | 1982 | 19 | 0.010 |
Why?
| Risk | 1 | 1985 | 890 | 0.010 |
Why?
| Adenoma, Chromophobe | 1 | 1981 | 3 | 0.010 |
Why?
| Patient Compliance | 1 | 2006 | 561 | 0.010 |
Why?
| Radioimmunoassay | 2 | 1986 | 168 | 0.010 |
Why?
| Desipramine | 1 | 1981 | 9 | 0.010 |
Why?
| Mitral Valve Prolapse | 1 | 1981 | 8 | 0.010 |
Why?
| Motivation | 1 | 2006 | 515 | 0.010 |
Why?
| Tomography, X-Ray | 1 | 1981 | 4 | 0.010 |
Why?
| Alcoholic Intoxication | 1 | 1982 | 66 | 0.010 |
Why?
| Thyroid Function Tests | 1 | 1981 | 11 | 0.010 |
Why?
| Prevalence | 1 | 2008 | 2442 | 0.010 |
Why?
| Parotid Gland | 1 | 1980 | 25 | 0.010 |
Why?
| Triiodothyronine | 1 | 1981 | 45 | 0.010 |
Why?
| Survival Rate | 1 | 2005 | 1810 | 0.010 |
Why?
| Hyperphagia | 1 | 1980 | 32 | 0.010 |
Why?
| Apolipoprotein C-II | 1 | 1980 | 1 | 0.010 |
Why?
| Apolipoprotein C-III | 1 | 1980 | 13 | 0.010 |
Why?
| Food | 1 | 1982 | 164 | 0.010 |
Why?
| Eating | 1 | 1983 | 379 | 0.010 |
Why?
| Pseudomonas Infections | 1 | 1982 | 198 | 0.010 |
Why?
| Creatinine | 1 | 1982 | 510 | 0.010 |
Why?
| Infarction | 1 | 1979 | 17 | 0.010 |
Why?
| Apolipoproteins E | 1 | 1980 | 91 | 0.010 |
Why?
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1982 | 187 | 0.010 |
Why?
| Cerebral Infarction | 1 | 1979 | 45 | 0.010 |
Why?
| Spinal Cord Diseases | 1 | 1979 | 39 | 0.010 |
Why?
| Lipolysis | 1 | 1979 | 43 | 0.010 |
Why?
| Clofibrate | 1 | 1979 | 5 | 0.010 |
Why?
| Exercise | 1 | 2010 | 1743 | 0.010 |
Why?
| Cerebral Arteries | 1 | 1979 | 56 | 0.010 |
Why?
| Feeding and Eating Disorders | 1 | 1980 | 127 | 0.010 |
Why?
| Antibodies, Monoclonal | 1 | 1985 | 1306 | 0.010 |
Why?
| Adenocarcinoma | 1 | 1985 | 837 | 0.010 |
Why?
| Arrhythmias, Cardiac | 1 | 1981 | 310 | 0.010 |
Why?
| Prospective Studies | 1 | 2010 | 6704 | 0.010 |
Why?
| Lipid Peroxides | 1 | 1997 | 8 | 0.010 |
Why?
| Radiography | 1 | 1981 | 888 | 0.010 |
Why?
| Heparin | 1 | 1979 | 240 | 0.010 |
Why?
| Thiobarbituric Acid Reactive Substances | 1 | 1997 | 24 | 0.010 |
Why?
| Ambulatory Care | 1 | 1982 | 497 | 0.010 |
Why?
| Secretin | 1 | 1977 | 4 | 0.010 |
Why?
| Depressive Disorder | 1 | 1981 | 347 | 0.010 |
Why?
| Methods | 1 | 1977 | 67 | 0.010 |
Why?
| Bile | 1 | 1977 | 31 | 0.010 |
Why?
| Duodenum | 1 | 1977 | 65 | 0.010 |
Why?
| Bilirubin | 1 | 1977 | 95 | 0.010 |
Why?
| Intestinal Absorption | 1 | 1977 | 106 | 0.010 |
Why?
| Intubation, Gastrointestinal | 1 | 1977 | 61 | 0.010 |
Why?
| Hypercholesterolemia | 1 | 1997 | 96 | 0.010 |
Why?
| Polymorphism, Single-Stranded Conformational | 1 | 1996 | 32 | 0.010 |
Why?
| Sodium | 1 | 1977 | 204 | 0.010 |
Why?
| Erythrocytes | 1 | 1981 | 636 | 0.010 |
Why?
| Hematocrit | 1 | 1976 | 94 | 0.010 |
Why?
| Tetany | 1 | 1976 | 3 | 0.010 |
Why?
| Follow-Up Studies | 1 | 2005 | 4768 | 0.010 |
Why?
| Magnesium Sulfate | 1 | 1976 | 19 | 0.010 |
Why?
| Evaluation Studies as Topic | 2 | 1987 | 190 | 0.010 |
Why?
| Calcification, Physiologic | 1 | 1976 | 33 | 0.010 |
Why?
| Risk Assessment | 1 | 2005 | 3213 | 0.010 |
Why?
| Rats | 1 | 1984 | 5426 | 0.010 |
Why?
| Cholangiography | 1 | 1975 | 20 | 0.010 |
Why?
| DNA, Neoplasm | 1 | 1996 | 155 | 0.010 |
Why?
| Erythrocyte Count | 1 | 1975 | 19 | 0.010 |
Why?
| Common Bile Duct | 1 | 1975 | 16 | 0.010 |
Why?
| Radioisotopes | 1 | 1975 | 36 | 0.010 |
Why?
| Selenium | 1 | 1975 | 39 | 0.010 |
Why?
| Metabolic Clearance Rate | 2 | 1986 | 111 | 0.010 |
Why?
| Exons | 1 | 1996 | 310 | 0.010 |
Why?
| Bone Diseases | 1 | 1976 | 60 | 0.010 |
Why?
| DNA Mutational Analysis | 1 | 1996 | 390 | 0.010 |
Why?
| Laparotomy | 1 | 1975 | 109 | 0.010 |
Why?
| Cardiomegaly | 1 | 1976 | 168 | 0.010 |
Why?
| Inflammation | 1 | 2005 | 2598 | 0.010 |
Why?
| Fatty Acids, Nonesterified | 1 | 1975 | 173 | 0.010 |
Why?
| Leukocyte Count | 1 | 1975 | 309 | 0.010 |
Why?
| Disease Models, Animal | 1 | 1984 | 3799 | 0.010 |
Why?
| Hemoglobins | 1 | 1976 | 293 | 0.010 |
Why?
| Leukocytes | 1 | 1996 | 295 | 0.010 |
Why?
| Pituitary Function Tests | 1 | 1993 | 4 | 0.010 |
Why?
| Orbit | 1 | 1993 | 50 | 0.010 |
Why?
| Pituitary Gland | 1 | 1993 | 164 | 0.010 |
Why?
| Thyrotropin-Releasing Hormone | 2 | 1982 | 13 | 0.010 |
Why?
| Vitamin D | 1 | 1976 | 363 | 0.010 |
Why?
| Base Sequence | 1 | 1996 | 2186 | 0.010 |
Why?
| Infusions, Parenteral | 1 | 1991 | 38 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 1996 | 2933 | 0.010 |
Why?
| Endothelium, Vascular | 1 | 1997 | 923 | 0.010 |
Why?
| Child | 3 | 1996 | 19561 | 0.010 |
Why?
| Breast Neoplasms | 1 | 1982 | 1994 | 0.010 |
Why?
| Biopsy | 1 | 1993 | 1090 | 0.010 |
Why?
| Diabetic Ketoacidosis | 1 | 1991 | 173 | 0.010 |
Why?
| Liver | 2 | 1986 | 1827 | 0.000 |
Why?
| Random Allocation | 1 | 1987 | 360 | 0.000 |
Why?
| Bread | 1 | 1986 | 4 | 0.000 |
Why?
| Danazol | 1 | 1985 | 4 | 0.000 |
Why?
| Bromocriptine | 1 | 1985 | 28 | 0.000 |
Why?
| Menstruation | 1 | 1985 | 35 | 0.000 |
Why?
| Pyridoxine | 1 | 1985 | 27 | 0.000 |
Why?
| Cyclooxygenase Inhibitors | 1 | 1985 | 72 | 0.000 |
Why?
| Child, Preschool | 1 | 1979 | 9755 | 0.000 |
Why?
| False Negative Reactions | 1 | 1984 | 59 | 0.000 |
Why?
| Postoperative Complications | 1 | 1976 | 2301 | 0.000 |
Why?
| Proinsulin | 1 | 1984 | 49 | 0.000 |
Why?
| Aged, 80 and over | 1 | 1996 | 6845 | 0.000 |
Why?
| Progesterone | 1 | 1985 | 243 | 0.000 |
Why?
| Antidepressive Agents | 1 | 1985 | 194 | 0.000 |
Why?
| Psychotherapy | 1 | 1985 | 180 | 0.000 |
Why?
| Digestive System | 1 | 1983 | 30 | 0.000 |
Why?
| Catecholamines | 1 | 1983 | 103 | 0.000 |
Why?
| Estrogens | 1 | 1985 | 325 | 0.000 |
Why?
| Exophthalmos | 1 | 1982 | 16 | 0.000 |
Why?
| Chlorpropamide | 1 | 1982 | 1 | 0.000 |
Why?
| Calcitonin | 1 | 1982 | 28 | 0.000 |
Why?
| Kinetics | 1 | 1986 | 1658 | 0.000 |
Why?
| In Vitro Techniques | 1 | 1984 | 1130 | 0.000 |
Why?
| Thyroidectomy | 1 | 1982 | 54 | 0.000 |
Why?
| Substance Withdrawal Syndrome | 1 | 1984 | 159 | 0.000 |
Why?
| Magnetic Resonance Imaging | 1 | 1993 | 3264 | 0.000 |
Why?
| Coronary Circulation | 1 | 1981 | 121 | 0.000 |
Why?
| Isotope Labeling | 1 | 1981 | 76 | 0.000 |
Why?
| Propranolol | 1 | 1981 | 52 | 0.000 |
Why?
| Alkalosis | 1 | 1980 | 2 | 0.000 |
Why?
| Amylases | 1 | 1980 | 14 | 0.000 |
Why?
| Anorexia Nervosa | 1 | 1982 | 76 | 0.000 |
Why?
| Microscopy, Electron | 1 | 1981 | 418 | 0.000 |
Why?
| Hypertrophy | 1 | 1980 | 125 | 0.000 |
Why?
| Islets of Langerhans | 1 | 1986 | 749 | 0.000 |
Why?
| Indicators and Reagents | 1 | 1979 | 102 | 0.000 |
Why?
| Testosterone | 1 | 1982 | 353 | 0.000 |
Why?
| Gels | 1 | 1979 | 90 | 0.000 |
Why?
| Heterozygote | 1 | 1979 | 270 | 0.000 |
Why?
| Pedigree | 1 | 1979 | 492 | 0.000 |
Why?
| Heart | 1 | 1981 | 649 | 0.000 |
Why?
| Depression | 1 | 1985 | 1190 | 0.000 |
Why?
| Kidney | 1 | 1984 | 1355 | 0.000 |
Why?
| Genetic Variation | 1 | 1979 | 952 | 0.000 |
Why?
|
|
Falko's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|